Zymergen Inc logo

Zymergen Inc

$ 3.37 +0.26 (+8.36%) 04:00 PM EST
P/E:
At Loss
P/B:
1.03
Market Cap:
$ 349.25M
Enterprise V:
$ 225.78M
Volume:
2.31M
Avg Vol (2M):
1.92M
Also Trade In:
Volume:
2.31M
Market Cap $:
349.25M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.92M
Enterprise Value $:
225.78M
PB Ratio:
1.03
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Zymergen Inc
NAICS : 325998 SIC : 2899
5980 Horton Street, Suite 105, Emeryville, CA, USA, 94608
Description
Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.
Name Current Vs Industry Vs History
Cash-To-Debt 1.41
Equity-to-Asset 0.56
Debt-to-Equity 0.7
Debt-to-EBITDA -0.78
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.24
Distress
Grey
Safe
Beneish M-Score -2.56
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 71.64
9-Day RSI 73.89
14-Day RSI 73.19
6-1 Month Momentum % -52.3
12-1 Month Momentum % -80.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4
Quick Ratio 3.93
Cash Ratio 3.81
Days Inventory 35.72
Days Sales Outstanding 43.06
Days Payable 63.47

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-16 Est.)

ZY's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ZY

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 17.562
EPS (TTM) ($) -3.72
Beta 0
Volatility % 136.22
14-Day RSI 73.19
14-Day ATR ($) 0.295375
20-Day SMA ($) 2.5565
12-1 Month Momentum % -80.3
52-Week Range ($) 1.1 - 14.68
Shares Outstanding (Mil) 104.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Zymergen Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More